These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18221133)

  • 1. Recent advances in flavivirus antiviral drug discovery and vaccine development.
    Ray D; Shi PY
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):45-55. PubMed ID: 18221133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional and novel approaches to flavivirus vaccines.
    Pugachev KV; Guirakhoo F; Trent DW; Monath TP
    Int J Parasitol; 2003 May; 33(5-6):567-82. PubMed ID: 12782056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets for flavivirus drug discovery.
    Sampath A; Padmanabhan R
    Antiviral Res; 2009 Jan; 81(1):6-15. PubMed ID: 18796313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.
    Ishikawa T; Yamanaka A; Konishi E
    Vaccine; 2014 Mar; 32(12):1326-37. PubMed ID: 24486372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in flavivirus vaccines with special attention to yellow fever.
    Pugachev KV; Guirakhoo F; Monath TP
    Curr Opin Infect Dis; 2005 Oct; 18(5):387-94. PubMed ID: 16148524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flaviviruses and flavivirus vaccines.
    Heinz FX; Stiasny K
    Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
    Lai CJ; Monath TP
    Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic acid-based inhibition of flavivirus infections.
    Stein DA; Shi PY
    Front Biosci; 2008 Jan; 13():1385-95. PubMed ID: 17981637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel antivirals against flaviviruses.
    Patkar CG; Kuhn RJ
    Novartis Found Symp; 2006; 277():41-52; discussion 52-6, 71-3, 251-3. PubMed ID: 17319153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines.
    Eckels KH; Putnak R
    Adv Virus Res; 2003; 61():395-418. PubMed ID: 14714438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis.
    Chong HY; Leow CY; Abdul Majeed AB; Leow CH
    Virus Res; 2019 Dec; 274():197770. PubMed ID: 31626874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in flavivirus vaccine development.
    Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
    IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live flavivirus vaccines: reasons for caution.
    Seligman SJ; Gould EA
    Lancet; 2004 Jun; 363(9426):2073-5. PubMed ID: 15207960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular Targets for the Treatment of Flavivirus Infections.
    Zakaria MK; Carletti T; Marcello A
    Front Cell Infect Microbiol; 2018; 8():398. PubMed ID: 30483483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advancement in flavivirus vaccine development.
    Chang GJ; Kuno G; Purdy DE; Davis BS
    Expert Rev Vaccines; 2004 Apr; 3(2):199-220. PubMed ID: 15056045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research advances in plant-made flavivirus antigens.
    Martínez CA; Giulietti AM; Talou JR
    Biotechnol Adv; 2012; 30(6):1493-505. PubMed ID: 22480936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Roadmap for Tick-Borne Flavivirus Research in the "Omics" Era.
    Grabowski JM; Hill CA
    Front Cell Infect Microbiol; 2017; 7():519. PubMed ID: 29312896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.
    Pastorino B; Nougairède A; Wurtz N; Gould E; de Lamballerie X
    Antiviral Res; 2010 Sep; 87(3):281-94. PubMed ID: 20452379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antiviral activity of adenosine analog NITD008 against tick-borne flaviviruses.
    Lo MK; Shi PY; Chen YL; Flint M; Spiropoulou CF
    Antiviral Res; 2016 Jun; 130():46-9. PubMed ID: 27016316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of flavivirus vaccines.
    Barrett AD
    Ann N Y Acad Sci; 2001 Dec; 951():262-71. PubMed ID: 11797783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.